扶脾舒肝汤联合双歧杆菌三联活菌胶囊治疗胆囊息肉术后慢性腹泻肝郁乘脾证临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.34

基金项目:


Clinical Study on Fupi Shugan Tang Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules for Chronic Diarrhea After Surgery of Gallbladder Polyps with Liver Constraint Overwhelming Spleen
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察扶脾舒肝汤联合双歧杆菌三联活菌胶囊治疗胆囊息肉术后慢性腹泻肝郁乘脾证的临床疗效。方法:选取80 例胆囊息肉术后慢性腹泻肝郁乘脾证患者,按随机数字表法分为对照组和观察组,每组40 例。对照组予以双歧杆菌三联活菌胶囊治疗,观察组在对照组基础上予以扶脾舒肝汤治疗,2 组均治疗8 周。比较2 组临床疗效,大便次数、性状,营养状态,肠道菌群,肠黏膜损伤程度及不良反应发生率。结果:观察组总有效率95.00%,高于对照组77.50% (P<0.05)。治疗后,2 组大便性状评分均较治疗前降低(P<0.05),大便次数均较治疗前减少(P<0.05);观察组大便性状评分低于对照组(P<0.05),大便次数少于对照组(P<0.05)。治疗后,2 组血红蛋白(Hb) 水平、体质量指数(BMI) 均较治疗前升高(P<0.05),患者提供的主观整体营养状况评估量表(PG-SGA) 评分均较治疗前降低(P<0.05);观察组Hb 水平、BMI 均高于对照组(P<0.05),PG-SGA 评分低于对照组(P<0.05)。治疗后,2 组大肠杆菌水平均较治疗前降低(P<0.05),双歧杆菌、乳酸杆菌水平均较治疗前升高(P<0.05);观察组大肠杆菌水平低于对照组(P<0.05),双歧杆菌、乳酸杆菌水平均高于对照组(P<0.05)。治疗后,2 组肠黏膜损伤评分均较治疗前降低(P<0.05),观察组肠黏膜损伤评分低于对照组(P<0.05)。观察组不良反应发生率10.00%,对照组不良反应发生率5.00%,2 组比较,差异无统计学意义(P>0.05)。结论:扶脾舒肝汤联合双歧杆菌三联活菌胶囊治疗胆囊息肉术后慢性腹泻肝郁乘脾证疗效较好,可改善患者的营养状态,调节肠道菌群,减少肠黏膜损伤,且安全性高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Fupi Shugan Tang combined with live combined bifidobacterium, lactobacillus and enterococcus capsules for chronic diarrhea after surgery of gallbladder polyps with liver constraint overwhelming spleen. Methods: A total of 80 cases of patients with postoperative chronic diarrhea and syndrome of the liver constraint overwhelming the spleen were selected and divided into the control group and the observation group according to the random number table method,with 40 cases in each group. The control group was treated with Live combined bifidobacterium, lactobacillus and enterococcus capsules, and the observation group was additionally treated with Fupi Shugan Tang based on the treatment of the control group. Both groups were treated for eight weeks. Clinical effects, stool frequency, stool characteristics, nutritional status, intestinal flora, intestinal mucosal damage degree and the incidence of adverse reactions were compared between the two groups. Results:The total effective rate was 95.00% in the observation group,higher than that of 77.50% in the control group(P<0.05). After treatment,scores of stool characteristics in the two groups were decreased when compared with those before treatment(P<0.05),and the stool frequency was decreased(P<0.05); the score of stool characteristics in the observation group was lower than that in the control group(P< 0.05),and the stool frequency was less(P<0.05). After treatment,hemoglobin(Hb) levels and Body Mass Index(BMI) in the two groups were increased when compared with those before treatment(P<0.05),and scores of Patient- Generated Subjective Global Assessment(PG- SGA) were decreased(P<0.05);Hb level and BMI in the observation group were higher than those in the control group(P<0.05),and the PG-SGA score was lower(P<0.05). After treatment,escherichia coli levels in the two groups were decreased when compared with those before treatment(P<0.05), and levels of bifidobacterium and lactobacillus were increased(P<0.05);escherichia coli level in the observation group was lower than that in the control group (P<0.05),and levels of bifidobacterium and lactobacillus were higher(P<0.05). After treatment,scores of intestinal mucosal lesion in the two groups were decreased when compared with those before treatment (P<0.05),and the score in the observation group was lower than that in the control group(P<0.05). The incidence of adverse reactions was 10.00% in the observation group and 5.00% in the control group,there being no significance in the difference(P>0.05). Conclusion: Fupi Shugan Tang combined with live combined bifidobacterium,lactobacillus and enterococcus capsules have a good curative effect in treating postoperative chronic diarrhea in patients with gallbladder polyps and liver constraint overwhelming the spleen syndrome. It can improve the nutritional status of patients, regulate intestinal flora, and reduce intestinal mucosal damage,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

潘迎春,黄海,李晓文,林达.扶脾舒肝汤联合双歧杆菌三联活菌胶囊治疗胆囊息肉术后慢性腹泻肝郁乘脾证临床研究[J].新中医,2022,54(22):84-88

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-11-27
  • 出版日期: